Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent
1996-02-12
1998-09-29
Fitzgerald, David L.
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
530351, 530424, C07K 1455, A61K 3820
Patent
active
058143149
ABSTRACT:
A biologically active, non-glycosylated recombinant human Interleukin 2 (R-hIL.sub.2) in reduced form, process for its preparation and method of use.
REFERENCES:
patent: 4518584 (1985-05-01), Mark et al.
patent: 4569790 (1986-02-01), Koths et al.
patent: 4604377 (1986-08-01), Fernandes et al.
patent: 4645830 (1987-02-01), Yasushi et al.
patent: 4690915 (1987-09-01), Rosenberg
Weir et al.. (Biochem J. 245: 85-92, 1987).
Robb et al.. (PNAS 80: 5990-94, 1983).
Yamada et al. 1987, (Arch. Biochem Biophys 257,197,.
Abecassis Pierre Yves
Lando Danielle
Riberon Philippe
Fitzgerald David L.
Uclaf Roussel
LandOfFree
Non-glycosylated, recombinant human IL .sub.2 in reduced form does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-glycosylated, recombinant human IL .sub.2 in reduced form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-glycosylated, recombinant human IL .sub.2 in reduced form will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-684064